Literature DB >> 17482131

HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.

Huafeng Zhang1, Ping Gao, Ryo Fukuda, Ganesh Kumar, Balaji Krishnamachary, Karen I Zeller, Chi V Dang, Gregg L Semenza.   

Abstract

Many cancer cells are characterized by increased glycolysis and decreased respiration, even under aerobic conditions. The molecular mechanisms underlying this metabolic reprogramming are unclear. Here we show that hypoxia-inducible factor 1 (HIF-1) negatively regulates mitochondrial biogenesis and O(2) consumption in renal carcinoma cells lacking the von Hippel-Lindau tumor suppressor (VHL). HIF-1 mediates these effects by inhibiting C-MYC activity via two mechanisms. First, HIF-1 binds to and activates transcription of the MXI1 gene, which encodes a repressor of C-MYC transcriptional activity. Second, HIF-1 promotes MXI-1-independent, proteasome-dependent degradation of C-MYC. We demonstrate that transcription of the gene encoding the coactivator PGC-1beta is C-MYC dependent and that loss of PGC-1beta expression is a major factor contributing to reduced respiration in VHL-deficient renal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482131     DOI: 10.1016/j.ccr.2007.04.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  399 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

2.  Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells.

Authors:  Shivani Ponnala; Chandramu Chetty; Krishna Kumar Veeravalli; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-11-07       Impact factor: 5.650

Review 3.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

4.  The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.

Authors:  Ching-yi Chang; Dmitri Kazmin; Jeff S Jasper; Rebecca Kunder; William J Zuercher; Donald P McDonnell
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

5.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 6.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 7.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 8.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  HIF-mediated metabolic switching in bladder outlet obstruction mitigates the relaxing effect of mitochondrial inhibition.

Authors:  Mari Ekman; Bengt Uvelius; Sebastian Albinsson; Karl Swärd
Journal:  Lab Invest       Date:  2014-03-03       Impact factor: 5.662

Review 10.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.